India
September 30, 2005
By Vivek Deshpande,
Indian Express
After facing criticism for years
of failure in developing its own Bt cotton, the
Central Institute for Cotton
Research (CICR) now has something concrete to claim. It has
been able to introduce the Cry1 Ac gene in an Indian cotton
variety and, if all goes well, the institute’s Bt will hit the
market in another two years.
Director B M Khadi is confident
the breed will be a success. "The CICR Bt will be an independent
variety, which the farmers won’t have to buy every year from the
market like the Bt hybrids available currently.
“Moreover, it will be much, much cheaper than those now
available," he said.
CICR has been trying to develop India’s own Bt since the early
1990s.
"At long last, we have standardised our own protocol (method)
for a primary transgenic variety. We call it meristem culture.
Using this method, we have put the Cry1 Ac Bt gene in the famous
Rajasthan variety, Bikaner Narma, and are currently testing it
under different environmental conditions across the country. The
results are very encouraging and there is little doubt that
we’ll be able to introduce our Bt in the market in two years,"
Khadi, who lad the research team at the University of
Agricultural Sciences, Dharwad, said.
Incidentally, primary transgenic is the original variety of the
seed, like the one developed and marketed by Monsanto. Secondary
transgenic varieties (hybrids), were developed under licence
from Monsanto by companies like Mahyco, Rasi, Ankur and
Nuzeweedu. While hybrid seeds have to be bought anew every year,
the primary variety can be preserved and used by the farmer in
successive years.
CICR scientists have also introduced the gene in three other
varieties - LRA 1566, LRK 516 and RG 8 (Desi cotton) - and the
initial trials are underway on the CICR campus. But their
efficacy is yet to be established, unlike the Bikaner Narma
modifications.
"We were always interested in the primary transgenic variety.
Initially, we tried to use Monsanto’s somatic embryogenesis
method on Indian varieties, but we failed. Cotton is
acknowledged to be a very tough crop from the bio-technological
point of view. Even the Monsanto method was successful on only
two American varieties, Coker 312 and Coker 310. Similar efforts
have failed in China too," Khadi said.
According to the CICR director, besides his own institute, only
China has succeeded in developing its own protocol, Pollen 2
Pathway. ‘‘After an open field trial at the CICR, the Bikaner
Narma is currently under trial at nine select stations in south
and central India. One year later, we will subject it to
multi-locational trials (on select plots) and large-scale trials
(on farmer’s fields)," Khadi said.
"We hope the final results will be good and our Bt will be ready
to hit the fields in two years," he added.
Bet on Bt
- CICR Bt will be much
cheaper than hybrid varieties currently available
- Farmers can preserve seeds
for use in next season
- Field trials on under
varied environmental conditions
© 2005:
Indian Express
Newspapers (Mumbai) Ltd. |